137 related articles for article (PubMed ID: 20632268)
1. Association of visceral adiposity with oesophageal and junctional adenocarcinomas.
Beddy P; Howard J; McMahon C; Knox M; de Blacam C; Ravi N; Reynolds JV; Keogan MT
Br J Surg; 2010 Jul; 97(7):1028-34. PubMed ID: 20632268
[TBL] [Abstract][Full Text] [Related]
2. Prospective comparison of endosonography, computed tomography, and histopathological stage of junctional oesophagogastric cancer.
Blackshaw G; Lewis WG; Hopper AN; Morgan MA; Al-Khyatt W; Edwards P; Roberts SA
Clin Radiol; 2008 Oct; 63(10):1092-8. PubMed ID: 18774355
[TBL] [Abstract][Full Text] [Related]
3. Transabdominal ultrasonography in achalasia.
Eckardt VF; Schmitt T; Kanzler G
Scand J Gastroenterol; 2004 Jul; 39(7):634-7. PubMed ID: 15370683
[TBL] [Abstract][Full Text] [Related]
4. Semiautomated Measure of Abdominal Adiposity Using Computed Tomography Scan Analysis.
Srikumar T; Siegel EM; Gu Y; Balagurunathan Y; Garcia AL; Chen YA; Zhou JM; Zhao X; Gillies R; Clark W; Gamenthaler A; Choi J; Shibata D
J Surg Res; 2019 May; 237():12-21. PubMed ID: 30694786
[TBL] [Abstract][Full Text] [Related]
5. Diverse contributions of the visceral fat area to the etiology of two distinct subtypes of esophago-gastric junctional adenocarcinoma.
Watanabe K; Koizumi S; Shirane K; Tsuda H; Watanabe H; Tsuji T; Onochi K; Yamai K; Kusano C; Dohmen T; Horikawa Y; Ajimine T; Shimodaira Y; Matsuhashi T; Iijima K
Scand J Gastroenterol; 2022 Dec; 57(12):1463-1469. PubMed ID: 35737566
[TBL] [Abstract][Full Text] [Related]
6. Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma.
Howard JM; Beddy P; Ennis D; Keogan M; Pidgeon GP; Reynolds JV
Br J Surg; 2010 Jul; 97(7):1020-7. PubMed ID: 20632267
[TBL] [Abstract][Full Text] [Related]
7. Visceral obesity is associated with outcomes of total mesorectal excision for rectal adenocarcinoma.
Ballian N; Lubner MG; Munoz A; Harms BA; Heise CP; Foley EF; Kennedy GD
J Surg Oncol; 2012 Mar; 105(4):365-70. PubMed ID: 21751219
[TBL] [Abstract][Full Text] [Related]
8. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
[TBL] [Abstract][Full Text] [Related]
9. Modified classification for adenocarcinoma of the gastro-oesophageal junction.
Shearer CJ; Going JJ; Neilson LJ; Stuart RC
ANZ J Surg; 2007 Jul; 77(7):544-9. PubMed ID: 17610690
[TBL] [Abstract][Full Text] [Related]
10. Association between high visceral fat area and postoperative complications in patients with Crohn's disease following primary surgery.
Ding Z; Wu XR; Remer EM; Lian L; Stocchi L; Li Y; McCullough A; Remzi FH; Shen B
Colorectal Dis; 2016 Feb; 18(2):163-72. PubMed ID: 26391914
[TBL] [Abstract][Full Text] [Related]
11. Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma.
Donohoe CL; Doyle SL; McGarrigle S; Cathcart MC; Daly E; O'Grady A; Lysaght J; Pidgeon GP; Reynolds JV
Br J Surg; 2012 Mar; 99(3):387-96. PubMed ID: 22241325
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography for staging esophageal and gastroesophageal cancer: reevaluation.
Thompson WM; Halvorsen RA; Foster WL; Williford ME; Postlethwait RW; Korobkin M
AJR Am J Roentgenol; 1983 Nov; 141(5):951-8. PubMed ID: 6605068
[TBL] [Abstract][Full Text] [Related]
13. Effect of endoscopic ultrasonography on the management of 100 consecutive patients with oesophageal and junctional carcinoma.
Preston SR; Clark GW; Martin IG; Ling HM; Harris KM
Br J Surg; 2003 Oct; 90(10):1220-4. PubMed ID: 14515290
[TBL] [Abstract][Full Text] [Related]
14. [Siewert-Stein classification of adenocarcinoma of the esophagogastric junction].
Szántó I; Vörös A; Gonda G; Nagy P; Altorjay A; Banai J; Gamal EM; Cserepes E
Magy Seb; 2001 Jun; 54(3):144-9. PubMed ID: 11432164
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of visceral obesity on gastric adenocarcinoma: does it really matter?
Gürsoy Çoruh A; Uzun Ç; Akkaya Z; Avcı O; Adıgüzel M; Ersöz CC; Elhan AH
Clin Imaging; 2021 Aug; 76():228-234. PubMed ID: 33971589
[TBL] [Abstract][Full Text] [Related]
16. CT assessment of operability in carcinoma of the oesophagogastric junction.
Terrier F; Schapira C; Fuchs WA
Eur J Radiol; 1984 May; 4(2):114-7. PubMed ID: 6734608
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of the esophagogastric junction.
Balthazar EJ; Goldfine S; Davidian MM
Am J Gastroenterol; 1980 Sep; 74(3):237-43. PubMed ID: 7468559
[TBL] [Abstract][Full Text] [Related]
18. Computed tomography of the gastroesophageal junction.
Halvorsen RA; Thompson WA
Crit Rev Diagn Imaging; 1984; 21(3):183-228. PubMed ID: 6375968
[TBL] [Abstract][Full Text] [Related]
19. Visceral adipose tissue: the link with esophageal adenocarcinoma.
Massl R; van Blankenstein M; Jeurnink S; Hermans JJ; de Haan MC; Stoker J; Koek M; Niessen WJ; Steyerberg EW; Looman CW; Kuipers EJ
Scand J Gastroenterol; 2014 Apr; 49(4):449-57. PubMed ID: 24467299
[TBL] [Abstract][Full Text] [Related]
20. Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden.
Ljung R; Martin L; Lagergren J
Eur J Cancer; 2011 Sep; 47(14):2128-32. PubMed ID: 21489778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
